Co-Diagnostics IncNASDAQ:CODX
- LAST PRICE1.2100
- TODAY'S CHANGE (%)-0.0100 (-0.8197%)
- Bid / Lots1.1800/ 1
- Ask / Lots1.2400/ 100
- Open / Previous Close1.2200 / 1.2200
- Day Range
- 52 Week Range
- Volume43,131
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 291 | 1.22 |
| 09:46 ET | 861 | 1.2001 |
| 09:48 ET | 400 | 1.2102 |
| 10:02 ET | 393 | 1.21 |
| 10:09 ET | 995 | 1.2065 |
| 10:18 ET | 396 | 1.2044 |
| 10:38 ET | 284 | 1.2054 |
| 11:14 ET | 137 | 1.21 |
| 11:21 ET | 450 | 1.21 |
| 11:27 ET | 200 | 1.2199 |
| 11:36 ET | 150 | 1.2191 |
| 11:41 ET | 100 | 1.22 |
| 12:03 ET | 757 | 1.22 |
| 12:30 ET | 5225 | 1.23 |
| 12:35 ET | 100 | 1.23 |
| 12:46 ET | 100 | 1.23 |
| 01:24 ET | 100 | 1.22 |
| 01:29 ET | 3200 | 1.21 |
| 01:44 ET | 100 | 1.23 |
| 01:49 ET | 100 | 1.22 |
| 01:51 ET | 429 | 1.2267 |
| 01:56 ET | 500 | 1.215 |
| 02:05 ET | 100 | 1.21 |
| 02:21 ET | 100 | 1.215 |
| 02:52 ET | 500 | 1.2107 |
| 02:56 ET | 100 | 1.22 |
| 03:06 ET | 10900 | 1.19 |
| 03:10 ET | 1408 | 1.19 |
| 03:28 ET | 100 | 1.19 |
| 03:33 ET | 438 | 1.2 |
| 03:35 ET | 100 | 1.18 |
| 03:42 ET | 895 | 1.2 |
| 03:44 ET | 248 | 1.209 |
| 03:46 ET | 671 | 1.2001 |
| 03:48 ET | 218 | 1.2099 |
| 03:50 ET | 1672 | 1.205 |
| 03:53 ET | 747 | 1.22 |
| 03:55 ET | 577 | 1.22 |
| 03:57 ET | 1480 | 1.2199 |
| 04:00 ET | 1746 | 1.21 |
Today
Oct 25, 2024
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast, from 4:01PM ET on Friday Oct 25, 2024 by Dow Jones
4:01PM ET on Friday Oct 25, 2024 by Dow Jones
Oct 21, 2024
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024, from 9:30AM ET on Monday Oct 21, 2024 by Dow Jones
9:30AM ET on Monday Oct 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 38.9M | -1.0x | --- |
Icecure Medical Ltd | 42.1M | -2.7x | --- |
T2 Biosystems Inc | 14.0M | -0.1x | --- |
Neuroone Medical Technologies Corp | 28.6M | -1.8x | --- |
Renalytix PLC | 34.5M | -0.3x | --- |
Accelerate Diagnostics Inc | 44.3M | -1.0x | --- |
Company Information
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Contact Information
- Headquarters
- 4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664
- Phone
- 801-278-9769
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Dwight Egan
- President
- Richard Abbott
- Chief Financial Officer
- Brian Brown
- Chief Operations Officer
- David Nielsen
- Chief Technology Officer
- Christopher Thurston
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $38.9M |
|---|---|
Revenue (TTM) | $9.1M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.82 |
EPS | $-1.27 |
Book Value | $2.75 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 4.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -424.64% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
